Primary hepatocytes are widely accepted as a suitable model for studying in vitro pharmacokinetic properties of newly synthesized or repurposed compounds, including CYP inducibility and biotransformation rates in the liver, compared to tumorigenic cellular systems such as human hepatoma cell line HepG2 [36,37,38]. Here, PPIG is linked to hepatocellular carcinoma.